Navigation Links
Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board

SWARTZ CREEK, Mich., May 29 /PRNewswire/ -- Diplomat Specialty Pharmacy, a leader in specialty pharmacy services, disease management (DM) and drug therapy management (DTM) announced today that their specialty pharmacy was one of 3 sponsors of the National Managed Care Roundtable (NMCRT) held this month in Dallas, Texas. This forum brought 30 industry executives from top consulting and managed care organizations together to review and improve on the current offerings and directions of specialty pharmacy and other critical business segments.

"With our advisors high in the managed care hierarchy, their opinions carry weight in their organizations and within the managed care marketplace," stated Jim Smeeding, President of NMCRT. "I believe that Diplomat offered services that go above and beyond the usual expectations for a specialty pharmacy."

"Managed Care executives provided us with invaluable insights at the meeting. Their reviews will benefit us greatly as we continue to expand Diplomat on a national level," stated Phil Hagerman, President and CEO of Diplomat. "Consistent messages from the group included: the importance of patient care outcome reporting, the need for increased price transparency, the benefits of shared risk for disease management, and the need to maintain a high level of service to patients on specialty medications."

"The feedback from managed care organizations confirmed that specialty pharmacy is still a high priority within the pharmacy and medical benefits," stated Dr. Atheer Kaddis, Diplomat's Vice President of Managed Markets. "It also confirmed to us that there are very few, if any, successful care management models addressing kidney disease today. The programs presented by Diplomat Specialty Pharmacy to address specialty pharmacy and kidney disease were well received by managed care organizations and we are excited about future potential opportunities to work with managed care organizations in these priority areas."

Smeeding added that, "Diplomat was very well received by our advisors -- clearly there is an unmet need for managing these high cost, high acuity patients that Diplomat services. The feedback from our advisors should allow Diplomat to continue to expand their offerings with greater insights into what the marketplace demands and desires."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.


Established in 2006, National Managed Care Roundtable LLC (NMCRT) provides innovative, informational interchange programs to address the business and clinical issues of medical directors and pharmacy directors from health plans, pharmacy benefit management companies and physician groups. Typical sponsors include pharmaceutical companies, medical device, disease management and other companies offering products and services of interest to our advisors.

For more information contact:

Alecia Greilich


SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
10. Pharmacyclics Announces It Received Nasdaq Notification
11. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):